{"id":"https://openalex.org/W2606824928","doi":"https://doi.org/10.1182/blood.v128.22.623.623","title":"Single-Agent MOR208 in Relapsed or Refractory (R-R) Non-Hodgkin's Lymphoma (NHL): Results from Diffuse Large B-Cell Lymphoma (DLBCL) and Indolent NHL Subgroups of a Phase IIa Study","display_name":"Single-Agent MOR208 in Relapsed or Refractory (R-R) Non-Hodgkin's Lymphoma (NHL): Results from Diffuse Large B-Cell Lymphoma (DLBCL) and Indolent NHL Subgroups of a Phase IIa Study","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2606824928","doi":"https://doi.org/10.1182/blood.v128.22.623.623","mag":"2606824928"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.623.623","doi":"https://doi.org/10.1182/blood.v128.22.623.623","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.623.623","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102788725","display_name":"Wojciech J. Jurczak","orcid":"https://orcid.org/0000-0003-1879-8084","observed_orcids":["https://orcid.org/0000-0003-1879-8084"]},"institutions":[{"id":"https://openalex.org/I126596746","display_name":"Jagiellonian University","ror":"https://ror.org/03bqmcz70","country_code":"PL","type":"education","lineage":["https://openalex.org/I126596746"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Wojciech Jurczak","raw_affiliation_strings":["Department of Hematology, Jagiellonian University, Krakow, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Jagiellonian University, Krakow, Poland","institution_ids":["https://openalex.org/I126596746"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091882595","display_name":"Pier Luigi Zinzani","orcid":"https://orcid.org/0000-0002-2112-2651","observed_orcids":["https://orcid.org/0000-0002-2112-2651"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Pier Luigi Zinzani","raw_affiliation_strings":["Institute of Hematology, University of Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Hematology, University of Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041745367","display_name":"Gianluca Ga\u00efdano","orcid":"https://orcid.org/0000-0002-4681-0151","observed_orcids":["https://orcid.org/0000-0002-4681-0151"]},"institutions":[{"id":"https://openalex.org/I123338534","display_name":"Universit\u00e0 degli Studi del Piemonte Orientale \u201cAmedeo Avogadro\u201d","ror":"https://ror.org/04387x656","country_code":"IT","type":"education","lineage":["https://openalex.org/I123338534"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gianluca Gaidano","raw_affiliation_strings":["Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy","institution_ids":["https://openalex.org/I123338534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089882481","display_name":"Andre Henri Goy","orcid":"https://orcid.org/0000-0001-5125-6522","observed_orcids":["https://orcid.org/0000-0001-5125-6522"]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andre Goy","raw_affiliation_strings":["John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085499011","display_name":"Mariano Provencio","orcid":"https://orcid.org/0000-0001-9053-9197","observed_orcids":["https://orcid.org/0000-0001-9053-9197"]},"institutions":[{"id":"https://openalex.org/I4210105637","display_name":"Hospital Universitario Puerta de Hierro Majadahonda","ror":"https://ror.org/01e57nb43","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210105637","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Mariano Provencio","raw_affiliation_strings":["Department of Medical Oncology, University Hospital Puerta De Hierro, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, University Hospital Puerta De Hierro, Madrid, Spain","institution_ids":["https://openalex.org/I4210105637"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101865823","display_name":"Zsolt Nagy","orcid":"https://orcid.org/0000-0001-9756-5427","observed_orcids":["https://orcid.org/0000-0001-9756-5427"]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":true,"raw_author_name":"Zsolt Nagy","raw_affiliation_strings":["First Department of Internal Medicine, Semmelweis University, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Internal Medicine, Semmelweis University, Budapest, Hungary","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087571749","display_name":"Tadeusz Robak","orcid":"https://orcid.org/0000-0002-3411-6357","observed_orcids":["https://orcid.org/0000-0002-3411-6357"]},"institutions":[{"id":"https://openalex.org/I4210122071","display_name":"Medical University of Lodz","ror":"https://ror.org/02t4ekc95","country_code":"PL","type":"education","lineage":["https://openalex.org/I4210122071"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Tadeusz Robak","raw_affiliation_strings":["Department of Hematology, Medical University of Lodz, Lodz, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, Medical University of Lodz, Lodz, Poland","institution_ids":["https://openalex.org/I4210122071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024389256","display_name":"Kami J. Maddocks","orcid":"https://orcid.org/0000-0001-8519-8404","observed_orcids":["https://orcid.org/0000-0001-8519-8404"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kami J. Maddocks","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022277766","display_name":"Christian Buske","orcid":"https://orcid.org/0000-0002-9782-9012","observed_orcids":["https://orcid.org/0000-0002-9782-9012"]},"institutions":[{"id":"https://openalex.org/I196349391","display_name":"Universit\u00e4t Ulm","ror":"https://ror.org/032000t02","country_code":"DE","type":"education","lineage":["https://openalex.org/I196349391"]},{"id":"https://openalex.org/I4210155144","display_name":"University Hospital Ulm","ror":"https://ror.org/05emabm63","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210155144"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christian Buske","raw_affiliation_strings":["Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital of Ulm, Ulm, Germany","institution_ids":["https://openalex.org/I196349391","https://openalex.org/I4210155144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007316044","display_name":"Sumeet Ambarkhane","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Sumeet Ambarkhane","raw_affiliation_strings":["MorphoSys AG, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MorphoSys AG, Martinsried, Germany","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054420604","display_name":"Mark Winderlich","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Mark Winderlich","raw_affiliation_strings":["MorphoSys AG, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MorphoSys AG, Martinsried, Germany","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050782079","display_name":"Maren Dirnberger\u2010Hertweck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Maren Dirnberger-Hertweck","raw_affiliation_strings":["MorphoSys AG, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MorphoSys AG, Martinsried, Germany","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079112201","display_name":"Jan Endell","orcid":"https://orcid.org/0000-0002-9790-4414","observed_orcids":["https://orcid.org/0000-0002-9790-4414"]},"institutions":[{"id":"https://openalex.org/I144094060","display_name":"MorphoSys (Germany)","ror":"https://ror.org/00ew7rg06","country_code":"DE","type":"company","lineage":["https://openalex.org/I144094060"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Jan Endell","raw_affiliation_strings":["MorphoSys AG, Martinsried, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MorphoSys AG, Martinsried, Germany","institution_ids":["https://openalex.org/I144094060"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056946123","display_name":"Kristie A. Blum","orcid":"https://orcid.org/0000-0001-7363-9794","observed_orcids":["https://orcid.org/0000-0001-7363-9794","https://orcid.org/0000-0003-4229-2569"]},"institutions":[{"id":"https://openalex.org/I2799885155","display_name":"The Ohio State University Comprehensive Cancer Center \u2013 Arthur G. James Cancer Hospital and Richard J. Solove Research Institute","ror":"https://ror.org/028t46f04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799885155","https://openalex.org/I2802841970"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kristie A Blum","raw_affiliation_strings":["Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, OH","institution_ids":["https://openalex.org/I2799885155"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5007316044","https://openalex.org/A5050782079","https://openalex.org/A5054420604","https://openalex.org/A5056946123","https://openalex.org/A5079112201","https://openalex.org/A5085499011","https://openalex.org/A5101865823"],"corresponding_institution_ids":["https://openalex.org/I101202996","https://openalex.org/I144094060","https://openalex.org/I2799885155","https://openalex.org/I4210105637"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.7831,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.8437218,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"128","issue":"22","first_page":"623","last_page":"623"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/indolent-non-hodgkin-lymphoma","display_name":"indolent non-Hodgkin lymphoma","score":0.9399999976158142},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8500000238418579},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.6819999814033508},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7519999742507935},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7860000133514404},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8360000252723694}],"concepts":[{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.5958786606788635},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5774893164634705},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5203527808189392},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.519342303276062},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.5045677423477173},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.497083455324173},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.47525331377983093},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43455222249031067},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41331180930137634},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4061901271343231},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.30944398045539856},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.28278422355651855},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.25889867544174194}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.623.623","doi":"https://doi.org/10.1182/blood.v128.22.623.623","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.623.623","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2521775567","https://openalex.org/W2600991767","https://openalex.org/W2602241331","https://openalex.org/W2890781621","https://openalex.org/W2792232222","https://openalex.org/W2899239653","https://openalex.org/W2953058729","https://openalex.org/W2939294686","https://openalex.org/W2354995077","https://openalex.org/W2986154089"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"The":[2,80,217,379,545,570,668],"B-lymphocyte,":[3],"lineage":[4],"specific":[5],"surface":[6],"antigen":[7],"CD19":[8,45,63,77],"is":[9,30,74,129],"broadly":[10],"and":[11,53,59,93,160,246,260,265,280,294,305,316,352,359,364,372,390,407,429,453,466,474,524,531,538,552,557,561,564,582,613,623],"homogeneously":[12],"expressed":[13],"in":[14,37,50,121,138,184,263,290,297,342,355,367,387,392,397,404,445,462,495,521,528,559,566,580,584,601,617,631,686],"most":[15],"B-cell":[16,26,71,106,125,687],"non-Hodgkin's":[17],"lymphomas":[18],"(NHL).":[19],"As":[20],"a":[21,75,86,117,498,640,659,683],"co-stimulatory":[22],"molecule":[23],"of":[24,34,40,44,70,82,88,136,155,158,239,248,257,324,440,535,542,547,572,634,671,678,682,700,725,741,752,770,783,794,805,816,827,866,878,891,906,931],"the":[25,68,221,230,255,291,298,328,343,356,368,388,393,437,456,464,529,632,676],"receptor":[27,107],"complex":[28],"it":[29],"an":[31,64,130,697,722,738,749,767,780,791,802,813,824,863,875,888,903,928],"important":[32],"regulator":[33],"transmembrane":[35],"signals":[36],"B-cells.":[38],"Phosphorylation":[39],"intracellular":[41],"tyrosine":[42],"residues":[43],"may":[46,112],"augment":[47],"signal":[48],"transduction":[49],"multiple":[51],"pro-survival":[52],"proliferation":[54],"pathways":[55],"(":[56],"e.g.":[57],"PI3K":[58],"BTK).":[60],"This":[61,128,252],"makes":[62],"attractive":[65],"target":[66,398],"for":[67,172,180,420,432],"treatment":[69,214],"malignancies.":[72,126,688],"MOR208":[73,83,98,111,137,213,573,593,651,653,679],"Fc-enhanced":[76],"monoclonal":[78],"antibody.":[79],"Fc-enhancement":[81],"leads":[84],"to":[85],"potentiation":[87],"antibody-dependent":[89,94],"cell-mediated":[90,95],"cytotoxicity":[91],"(ADCC)":[92],"phagocytosis":[96],"(ADCP).":[97],"also":[99,402],"induces":[100],"direct":[101],"cytotoxicity,":[102],"potentially":[103,258],"by":[104,229],"disrupting":[105],"(BCR)":[108],"signalling.":[109],"Thus":[110],"have":[113],"clinical":[114],"use":[115],"as":[116,242,244,337,680],"new":[118],"therapeutic":[119],"agent":[120],"patients":[122,141,185,272,304,309,333,341,410,422,449,496,527,602,619,635,664],"with":[123,186,196,209,278,283,411,436,450,497,603,609,620,636,639,658],"(R-R)":[124],"Methods:":[127],"open-label,":[131],"multicenter,":[132],"phase":[133],"IIa":[134],"study":[135],"R-R":[139,604,607],"NHL":[140,618],"progressing":[142],"after":[143,192],"at":[144,187,204,646],"least":[145,188],"one":[146],"prior":[147,322],"rituximab-containing":[148],"therapy.":[149],"Patients":[150,195,638],"were":[151,273,334,338,375,489,519,590],"enrolled":[152,274],"into":[153],"1":[154],"4":[156,181],"cohorts":[157],"aggressive":[159],"indolent":[161],"(i)":[162],"NHLs.":[163],"Treatment":[164],"comprised":[165],"single-agent":[166,599],"MOR208,":[167],"12":[168,205,314,594],"mg/kg":[169,595],"IV,":[170],"weekly,":[171],"8":[173,365],"weeks":[174,183,206],"(2":[175],"cycles),":[176],"which":[177,226],"could":[178,207],"continue":[179,208],"additional":[182],"stable":[189],"disease":[190,380],"(SD)":[191],"2":[193,350],"cycles.":[194],"complete":[197],"responses":[198,202],"(CRs)":[199],"or":[200,211,606,702,727,743,754,772,785,796,807,818,829,868,880,893,908,933],"partial":[201],"(PRs)":[203],"bi-weekly":[210],"monthly":[212],"until":[215],"progression.":[216],"primary":[218],"endpoint":[219],"was":[220,227,287,347,385,401,417,460,492,554,578,614,629,654],"objective":[222],"response":[223,240,441],"rate":[224,382,459],"(ORR),":[225],"assessed":[228],"investigator.":[231],"Secondary":[232],"endpoints":[233],"included":[234],"progression-free":[235],"survival":[236],"(PFS),":[237],"duration":[238,439],"(DoR)":[241],"well":[243,656],"incidence":[245,546,571],"severity":[247],"adverse":[249,576],"events":[250,577],"(AEs).":[251],"analysis":[253],"includes":[254],"evaluation":[256],"predictive":[259],"prognostic":[261],"biomarkers":[262],"DLBCL":[264,279,292,303,329,357,389,406,421,465,530,560,581,605],"iNHL":[266,299,308,344,369,394,409,433,467,532,567,585],"cohorts.":[267,395,447,468],"Results:":[268],"In":[269,327,448],"total,":[270],"92":[271],"including":[275,349,361,663],"35":[276],"(38%)":[277],"45":[281],"(49%)":[282,340],"iNHL.":[284],"Median":[285,415],"age":[286],"71":[288],"years":[289,296],"cohort":[293,330],"66":[295],"cohort.":[300,345],"30":[301],"(86%)":[302],"40":[306],"(89%)":[307],"had":[310,319],"stage":[311],"III-IV":[312],"disease;":[313],"(34%)":[315],"21":[317],"(47%)":[318],"received":[320],"\u22653":[321,549],"lines":[323],"therapy,":[325],"respectively.":[326,378,569],"24":[331],"(69%)":[332],"rituximab":[335,376,451,621],"refractory":[336,454,622],"22":[339],"ORR":[346],"26%,":[348],"CRs":[351,363],"7":[353],"PRs":[354,366],"cohort,":[358],"29%":[360],"5":[362],"cohort;":[370],"5/9":[371],"5/13":[373],"responders":[374],"refractory,":[377],"control":[381],"(DCR,":[383],"CR+PR+SD)":[384],"40%":[386,461],"73%":[391],"Reduction":[396],"lesion":[399,627],"size":[400],"seen":[403,520],"5/6":[405],"12/16":[408],"SD":[412],"(central":[413],"assessment).":[414],"DoR":[416],"20":[418],"months":[419,444],"(95%":[423],"CI":[424,486,513],"11.3-not":[425],"available;":[426],"3":[427],"ongoing)":[428],"not":[430],"reached":[431],"(6":[434],"ongoing),":[435],"longest":[438],"lasting":[442,611],">26":[443],"both":[446,463],"non-refractory":[452,624],"tumors":[455],"12-month":[457],"PFS":[458,475,491],"DCR":[469],"(65%":[470],"vs":[471,478,507],"54%;":[472],"p=0.35)":[473],"(median":[476],"6.6":[477],"5.3":[479],"months,":[480],"hazard":[481],"ratio":[482],"[HR]":[483],"0.85,":[484],"95%":[485,512],"0.45-1.6;":[487],"p=0.59)":[488],"comparable.":[490],"significantly":[493],"longer":[494],"baseline":[499,647],"natural":[500],"killer":[501],"(NK)":[502],"cell":[503,644],"count":[504,645],">100":[505],"cells/\u03bcl":[506],"\u2264100":[508],"cells/\u03bcl,":[509],"(HR":[510],"0.16,":[511],"0.06-0.42,":[514],"p=0.0003).":[515],"Infusion-related":[516],"reactions":[517],"(IRRs)":[518],"4/35":[522],"(11%)":[523,526],"5/45":[525],"cohorts,":[533],"mostly":[534],"grade":[536,548],"1-2":[537],"duringthe":[539],"first":[540],"infusion":[541],"cycle":[543],"1.":[544],"neutropenia,":[550],"anemia":[551],"thrombocytopenia":[553],"17%,":[555],"9%":[556],"6%":[558,579],"4%,":[562],"0%":[563],"2%":[565],"patients,":[568],"treatment-related":[574,588],"serious":[575],"4%":[583],"patients.":[586],"No":[587],"deaths":[589],"reported.":[591],"Conclusions:":[592],"showed":[596],"encouraging":[597],"preliminary":[598],"activity":[600],"iNHL,":[608],"long":[610],"responses,":[612],"equally":[615],"efficacious":[616],"disease.":[625],"Target":[626],"shrinkage":[628],"demonstrated":[630],"majority":[633],"SD.":[637],"high":[641],"peripheral":[642],"NK":[643],"benefited":[648],"more":[649],"from":[650],"treatment.":[652,667],"generally":[655],"tolerated,":[657],"favorable":[660],"safety":[661],"profile":[662],"on":[665,696,721,737,748,766,779,790,801,812,823,862,874,887,902,927],"long-term":[666],"promising":[669],"results":[670],"this":[672],"trial":[673],"further":[674],"justify":[675],"development":[677],"part":[681],"combination":[684],"therapy":[685],"Disclosures":[689],"Jurczak:":[690],"Pfizer:":[691],"Research":[692,705,708,711,714,717,758,761,896,919,936,941,945,969],"Funding;":[693,706,709,712,715,718,759,762,897],"Celgene:":[694,883],"Membership":[695,720,736,747,765,778,789,800,811,822,861,873,886,901,926],"entity's":[698,723,739,750,768,781,792,803,814,825,864,876,889,904,929],"Board":[699,724,740,751,769,782,793,804,815,826,865,877,890,905,930],"Directors":[701,726,742,753,771,784,795,806,817,828,867,879,892,907,932],"advisory":[703,728,744,755,773,786,797,808,819,830,869,881,894,909,934],"committees,":[704,729,774,895,910,935],"Gillead:":[707],"Janssen:":[710,821,848,916],"Celtrion:":[713],"Bayer:":[716],"Sandoz-Novartis:":[719],"Speakers":[730,733,775,835,846,851,856,914,921,938],"Bureau;":[731,734,836,847,852,915,922,939],"Roche:":[732,799],"Teva:":[735],"committees;":[745,756,787,798,809,820,870,882],"Abbvie:":[746,810],"Novartis:":[757,853],"Acerta:":[760],"MorphoSys:":[763,788,840],"Consultancy,":[764,833,838,841,844,849,854,859,872,884,899,917,924,949],"Bureau.":[776,857],"Zinzani:Celgene:":[777],"committees.":[831],"Gaidano:Roche:":[832],"Honoraria,":[834,845,850,855,860,885,900,918,925],"Karyopharm:":[837],"Honoraria;":[839,842],"Gilead:":[843],"Goy:Acerta:":[858],"Infinity:":[871],"Takeda:":[898],"Other:":[911],"Writing":[912],"support,":[913],"Funding,":[920,937],"Pharmacyclics:":[923],"Genentech:":[940],"Funding.":[942,946,970],"Robak:MorphoSys":[943],"AG:":[944,954,960,963],"Buske:Celltrion,":[947],"Inc.:":[948],"Honoraria.":[950],"Ambarkhane:MorphoSys:":[951],"Employment.":[952,961],"Winderlich:MorphoSys":[953],"Employment,":[955,964],"Patents":[956,965],"&":[957,966],"Royalties.":[958,967],"Dirnberger-Hertweck:MorphoSys":[959],"Endell:MorphoSys":[962],"Blum:MorphoSys:":[968]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-04-28T00:00:00"}